Product Name: Abaloparatide
CAS No: 247062-33-5
Purity: 95%
Molar Mass: 3960.59
Chemical Formula: C174H300N56O49
Synonyms: BA 058, BIM 44058, Eladynos
Storage: Store at -20℃
Sequence: AVSEHQLLHD KGKSIQDLRR RELLEKLLXK LHTA
Target: PTHR1
Application: Abaloparatide (CAS: 247062-33-5) is a notable pharmaceutical compound designed for the treatment of osteoporosis, particularly in postmenopausal women at an increased risk of fractures. Functioning as a parathyroid hormone-related protein (PTHrP) analog, abaloparatide stimulates bone formation by promoting osteoblast activity and increasing bone mineral density. Its mechanism involves selective activation of the PTH1 receptor, resulting in enhanced bone-building processes without a significant impact on bone resorption. By offering a balanced approach to bone remodeling, abaloparatide helps mitigate the risk of fractures effectively. This targeted intervention in bone metabolism positions abaloparatide as a valuable addition to pharmaceutical strategies, addressing the specific needs of individuals facing osteoporosis-related challenges and promoting skeletal health.
